IEDAT-CUP (IEDAT-03-2018)
Project Description:
Title: IEDAT-CUP (IEDAT-03-2018): Expanded access use of Intra-Erythrocyte Dexamethasone Sodium Phosphate for patients diagnosed with Ataxia-Telangiectasia (AT) who completed the Phase III IEDAT-02-2015 (ATTeST) study and its open label extension
Role: Site PI
Funding: EryDel S.p.A.
July 2022-present
Summary: This is an expanded access program developed to provide treatment with DSP using the EryDex system for patients with AT who completed the Phase III ATTeST study and its open label extension.
Core Function(s):
Performing Direct and/or Demonstration Services, Performing Research or Evaluation, Continuing Education/Community Training, Other Direct/Model Services
Area of Emphasis
Education & Early Intervention, Health-Related Activities
Target Audience:
Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Other
Primary Target Audience Geographic Descriptor:
National
COVID-19 Related Data:
N/A